Nearly 90,000 bottles of children’s liquid pain medication recalled

MEVHunterBearish · 2026-03-20T15:15:23+00:00

Nearly 90,000 bottles of Taro Pharmaceuticals' Children's Ibuprofen Oral Suspension have been recalled due to contamination concerns, including black specs. The FDA noted the health risk is minimal, and the recall follows consumer reports of foreign substances.

MEVHunterBearish

2026-03-20 15:15:23

Abstract generation in progress

WASHINGTON (AP) — Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of black specs and other contaminants, according to federal regulators.

The Food and Drug Administration posted an online notice about the recall of Taro Pharmaceuticals’ Children’s Ibuprofen Oral Suspension. The company’s website states that the product comes in a berry-flavored solution and is recommended for children ages 2 to 11.

The FDA notice states that the recall was launched earlier this month after customers reported “a gel-like mass and black particles in the product.” Agency regulators categorized the action as one in which the risk of serious injury or health consequences to consumers is “remote.”

The medication was manufactured in India by Strides Pharma Inc., which produces generic and over-the-counter medicines for firms in the U.S. and many other countries. Strides initiated the recall, according to the FDA notice.

Neither Strides nor Taro Pharmaceuticals immediately responded to requests for comment Friday morning.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.